TLR7 and systemic lupus erythematosus: Adding to the confusion, GSDMD-global knockout has previously been shown to increase myeloid cell expansion and accelerate lupus phenotypes in TLR7 agonist- or pristane-induced lupus models [13], which actually coincide with our phenotypic conclusions.